Polidori, D., Iijima, H., Goda, M., Maruyama, N., Inagaki, N., & Crawford, P. A. (2018). Intra‐ and inter‐subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co‐transporter 2 inhibitor canagliflozin. Diabetes Obes Metab.

Polidori, David, Hiroaki Iijima, Maki Goda, Nobuko Maruyama, Nobuya Inagaki, and Peter A. Crawford. "Intra‐ and Inter‐subject Variability for Increases in Serum Ketone Bodies in Patients With Type 2 Diabetes Treated With the Sodium Glucose Co‐transporter 2 Inhibitor Canagliflozin." Diabetes Obes Metab 2018.

Polidori, David, et al. "Intra‐ and Inter‐subject Variability for Increases in Serum Ketone Bodies in Patients With Type 2 Diabetes Treated With the Sodium Glucose Co‐transporter 2 Inhibitor Canagliflozin." Diabetes Obes Metab 2018.